Here, we revealed that KDM1A could control the PD-L1 expression level in HCC by demethylating myocyte enhancer factor 2D (MEF2D), a transcription factor promoting PD-L1 expression without methylation. This evidence concerns the gene CD274 and hepatocellular carcinoma.